Logo image of LCI

LANNETT CO INC (LCI) Stock Price, Quote, News and Overview

NYSE:LCI - New York Stock Exchange, Inc. - US5160122009 - Common Stock - Currency: USD

0.6855  +0.03 (+3.86%)

LCI Quote, Performance and Key Statistics

LANNETT CO INC

NYSE:LCI (4/19/2023, 8:06:04 PM)

0.6855

+0.03 (+3.86%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High3.72
52 Week Low0.64
Market Cap7.38M
Shares10.77M
Float8.57M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-02 2023-05-02/amc
IPO04-15 2002-04-15


LCI short term performance overview.The bars show the price performance of LCI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

LCI long term performance overview.The bars show the price performance of LCI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of LCI is 0.6855 USD. In the past month the price decreased by -59.68%. In the past year, price decreased by -74.42%.

LANNETT CO INC / LCI Daily stock chart

LCI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 71.52 882.60B
JNJ JOHNSON & JOHNSON 16.74 402.75B
NVO NOVO-NORDISK A/S-SPONS ADR 28.02 396.72B
AZN ASTRAZENECA PLC-SPONS ADR 21.02 236.00B
MRK MERCK & CO. INC. 12.19 235.64B
NVS NOVARTIS AG-SPONSORED ADR 13.93 218.48B
PFE PFIZER INC 8.44 148.76B
SNY SANOFI-ADR 14.17 141.71B
BMY BRISTOL-MYERS SQUIBB CO 52.52 121.43B
GSK GSK PLC-SPON ADR 8.09 77.44B
ZTS ZOETIS INC 28.81 76.94B
TAK TAKEDA PHARMACEUTIC-SP ADR 33.73 47.05B

About LCI

Company Profile

LCI logo image Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. The company is headquartered in Trevose, Pennsylvania and currently employs 564 full-time employees. The company went IPO on 2002-04-15. The firm markets approximately 100 products, mainly tablet, capsule or liquid oral generic medications. Its marketed products include generics such as Posaconazole, Fluphenazine, Levothyroxine, Sumatriptan and NDA-based product Numbrino. The Company’s product portfolio include Amphetamine IR Tablets, which are used to treat Attention deficit hyperactivity disorder (ADHD) and narcolepsy; Dicyclomine tablets, used for the treatment of functional bowel disorder and irritable bowel syndrome; Levothyroxine Capsules, used to treat patients with hypothyroidism and other conditions, and Numbrino Nasal Solution, used for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults, among others.

Company Info

LANNETT CO INC

1150 Northbrook Drive, Suite 155

Trevose PENNSYLVANIA 19136 US

CEO: Timothy C. Crew

Employees: 564

Company Website: https://www.lannett.com/

Phone: 12153339000.0

LANNETT CO INC / LCI FAQ

What is the stock price of LANNETT CO INC today?

The current stock price of LCI is 0.6855 USD. The price increased by 3.86% in the last trading session.


What is the ticker symbol for LANNETT CO INC stock?

The exchange symbol of LANNETT CO INC is LCI and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is LCI stock listed?

LCI stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for LANNETT CO INC stock?

9 analysts have analysed LCI and the average price target is 4.08 USD. This implies a price increase of 495.19% is expected in the next year compared to the current price of 0.6855. Check the LANNETT CO INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LANNETT CO INC worth?

LANNETT CO INC (LCI) has a market capitalization of 7.38M USD. This makes LCI a Nano Cap stock.


How many employees does LANNETT CO INC have?

LANNETT CO INC (LCI) currently has 564 employees.


Is LANNETT CO INC (LCI) expected to grow?

The Revenue of LANNETT CO INC (LCI) is expected to decline by -11.78% in the next year. Check the estimates tab for more information on the LCI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LANNETT CO INC (LCI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LANNETT CO INC (LCI) stock pay dividends?

LCI does not pay a dividend.


When does LANNETT CO INC (LCI) report earnings?

LANNETT CO INC (LCI) will report earnings on 2023-05-02, after the market close.


What is the Price/Earnings (PE) ratio of LANNETT CO INC (LCI)?

LANNETT CO INC (LCI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.44).


LCI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LCI Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to LCI. LCI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LCI Financial Highlights

Over the last trailing twelve months LCI reported a non-GAAP Earnings per Share(EPS) of -6.44. The EPS decreased by -129.18% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%12.82%
Sales Q2Q%-6.49%
EPS 1Y (TTM)-129.18%
Revenue 1Y (TTM)-24.09%

LCI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 47% to LCI. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of -3.01% and a revenue growth -11.78% for LCI


Ownership
Inst OwnersN/A
Ins Owners133.44%
Short Float %N/A
Short RatioN/A
Analysts
Analysts46.67
Price Target4.08 (495.19%)
EPS Next Y-3.01%
Revenue Next Year-11.78%